These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 21574259)
41. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4. De Angelis M; Buley ID; Heryet A; Gray W Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160 [TBL] [Abstract][Full Text] [Related]
42. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
43. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology. Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331 [TBL] [Abstract][Full Text] [Related]
44. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens]. Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967 [TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions. Lee JS; Nam JH; Lee MC; Park CS; Juhng SW Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877 [TBL] [Abstract][Full Text] [Related]
46. Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells. Davidson B; Xi Z; Saatcioglu F Diagn Cytopathol; 2007 Feb; 35(2):80-4. PubMed ID: 17230566 [TBL] [Abstract][Full Text] [Related]
47. The diagnostic role of claudins in serous effusions. Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990 [TBL] [Abstract][Full Text] [Related]
48. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
49. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Hyun TS; Barnes M; Tabatabai ZL Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894 [TBL] [Abstract][Full Text] [Related]
50. A panel of markers for identification of malignant and non-malignant cells in culture from effusions. Carneiro FP; Muniz-Junqueira MI; Pittella-Silva F; Carneiro MV; Takano GHS; Vianna LMS; De Andrade LB; De Castro TMML; Peres I; Dos Santos Borges TK; Ferreira VM; Motoyama AB Oncol Rep; 2017 Dec; 38(6):3538-3544. PubMed ID: 29039588 [TBL] [Abstract][Full Text] [Related]
51. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining. Kitazume H; Kitamura K; Mukai K; Inayama Y; Kawano N; Nakamura N; Sano J; Mitsui K; Yoshida S; Nakatani Y Cancer; 2000 Feb; 90(1):55-60. PubMed ID: 10692217 [TBL] [Abstract][Full Text] [Related]
52. The application of immunocytochemistry to direct smears in the diagnosis of effusions. Knoepp SM; Placido J; Fields KL; Thomas D; Roh MH Diagn Cytopathol; 2013 May; 41(5):425-30. PubMed ID: 22549950 [TBL] [Abstract][Full Text] [Related]
53. "Thick" cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma. Leong AS; Parkinson R; Milios J Diagn Cytopathol; 1990; 6(1):9-13. PubMed ID: 2323301 [TBL] [Abstract][Full Text] [Related]
54. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Davidson B; Baekelandt M; Shih IeM Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338 [TBL] [Abstract][Full Text] [Related]
55. Measurement of telomere length in cells from pleural effusion: Asbestos exposure causes telomere shortening in pleural mesothelial cells. Aida S; Aida J; Naoi M; Kato M; Tsuura Y; Natsume I; Takubo K Pathol Int; 2018 Sep; 68(9):503-508. PubMed ID: 30098092 [TBL] [Abstract][Full Text] [Related]
56. [Value of immunocytochemistry in differential diagnosis of gastric adenocarcinoma, reactive mesothelial cells and malignant epithelial mesothelioma in metastatic effusion fluid]. Lyu M; Cha N; Zou YF; Leng JH; Xu L; Sun Y; Hao YY Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):180-185. PubMed ID: 29534357 [No Abstract] [Full Text] [Related]
57. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping. Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402 [TBL] [Abstract][Full Text] [Related]
58. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma. Delahaye M; Hoogsteden HC; Van der Kwast TH J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800 [TBL] [Abstract][Full Text] [Related]
59. Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma. Üçer Ö; Dağli AF; Kiliçarslan A; Artaş G Turk Patoloji Derg; 2013; 29(2):94-100. PubMed ID: 23661345 [TBL] [Abstract][Full Text] [Related]
60. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]